@article{585f6beea46a4d4688596d985d02a8ee,
title = "Chronic myelogenous leukemia",
abstract = "CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)].",
keywords = "Allogenic HSCT, Chronic myelogenous leukemia, Cytogenetic response, Dasatinib, Hematologic response, Imatinib, Karyotyping, NCCN Clinical Practice Guidelines, Nilotinib, Transplantation",
author = "Susan O'Brien and Ellin Berman and Hossein Borghaei and DeAngelo, \{Daniel J.\} and Devetten, \{Marcel P.\} and Steven Devine and Erba, \{Harry P.\} and Jason Gotlib and Madan Jagasia and Moore, \{Joseph O.\} and Tariq Mughal and Javier Pinilla-Ibarz and Radich, \{Jerald P.\} and Shah, \{Neil P.\} and Shami, \{Paul J.\} and Smith, \{B. Douglas\} and Snyder, \{David S.\} and Tallman, \{Martin S.\} and Moshe Talpaz and Meir Wetzler",
year = "2009",
month = oct,
doi = "10.6004/jnccn.2009.0065",
language = "English",
volume = "7",
pages = "984--1023",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Harborside Press",
number = "9",
}